Canonico P L, Aronica E, Bruno V, Catania M V, Aleppo G, Galavotti F, Nicoletti F
Institute of Pharmacology, University of Catania, Italy.
Funct Neurol. 1990 Apr-Jun;5(2):121-6.
Single administration of PCA-Mg2+ (200 mg/kg, s.c.) increased the latency and shortened the duration of seizures produced by systemic injection of N-methyl-D-aspartate (NMDA) in mice. Mortality was reduced in mice pretreated with PCA-Mg2+. Single or repeated (twice a day for 5 days) injections of PCA-Mg2+ (250 mg/kg, i.p.) also attenuated kainate-induced seizures in rats. However, PCA-Mg2+ had no effect on kainate-induced automatisms but reduced the frequency of generalized seizures. These results indicate that pharmacological doses of Mg2+ protect experimental animals against excitatory amino acid-induced seizures.
皮下注射一次PCA-Mg2+(200毫克/千克)可延长小鼠全身注射N-甲基-D-天冬氨酸(NMDA)所致癫痫发作的潜伏期并缩短发作持续时间。经PCA-Mg2+预处理的小鼠死亡率降低。腹腔注射一次或重复(每天两次,共5天)注射PCA-Mg2+(250毫克/千克)也可减轻大鼠中由红藻氨酸诱发的癫痫发作。然而,PCA-Mg2+对红藻氨酸诱发的自动症没有影响,但可降低全身性癫痫发作的频率。这些结果表明,药理学剂量的Mg2+可保护实验动物免受兴奋性氨基酸诱发的癫痫发作。